Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →
Thplasma secures a $20 million financing round to advance its integrated plasma platform, including $15 million in equity and $5 million in venture debt.
PRIVATEAug 03, 2026•5 days ago
Amount Raised
$20 Million
Round Type
Venture - Series Unknown
Description
Thplasma, a U.S.-based pharmaceutical company, has announced a $20 million financing opportunity. This consists of a $15 million equity investment and a $5 million venture debt facility. The company aims to enhance its plasma therapeutics platform and develop its own IVIG and albumin biosimilars. With recurring revenue from long-term contracts, Thplasma is set to expand its market presence significantly.
Related People
Suggested for you
1 contactVerified contactsGeorge, Chief Executive Officer
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching True Health (THPlasma)? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan